Persons with dispensed medicines; age and sex

Persons with dispensed medicines; age and sex

Sex Ages Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female Total age C Cardiovascular system 2024* 21.51
Total male and female Total age C01 Cardiac therapy 2024* 2.50
Total male and female Total age C01A Cardiac glycosides 2024* 0.45
Total male and female Total age C01C Cardiac stimulants excl. glycosides 2024* 0.34
Total male and female Total age C01D Vasodilators used in card. diseases 2024* 1.38
Total male and female Total age C01E Other cardiac preparations 2024* 0.07
Total male and female Total age C08D Sel.calcium ch.block.direct cardiac 2024* 0.66
Total male and female Total age V09G Cardiovascular system 2024* 0.00
Total male and female 0 to 14 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 0 to 14 years C Cardiovascular system 2024* 0.76
Total male and female 0 to 14 years C01 Cardiac therapy 2024* 0.48
Total male and female 0 to 14 years C01A Cardiac glycosides 2024* 0.00
Total male and female 0 to 14 years C01C Cardiac stimulants excl. glycosides 2024* 0.47
Total male and female 0 to 14 years C01D Vasodilators used in card. diseases 2024* 0.00
Total male and female 0 to 14 years C01E Other cardiac preparations 2024* 0.00
Total male and female 0 to 14 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.00
Total male and female 0 to 14 years V09G Cardiovascular system 2024* 0.00
Total male and female 15 to 24 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 15 to 24 years C Cardiovascular system 2024* 2.02
Total male and female 15 to 24 years C01 Cardiac therapy 2024* 0.45
Total male and female 15 to 24 years C01A Cardiac glycosides 2024* 0.00
Total male and female 15 to 24 years C01C Cardiac stimulants excl. glycosides 2024* 0.42
Total male and female 15 to 24 years C01D Vasodilators used in card. diseases 2024* 0.00
Total male and female 15 to 24 years C01E Other cardiac preparations 2024* 0.02
Total male and female 15 to 24 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.03
Total male and female 15 to 24 years V09G Cardiovascular system 2024* 0.00
Total male and female 25 to 34 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 25 to 34 years C Cardiovascular system 2024* 3.09
Total male and female 25 to 34 years C01 Cardiac therapy 2024* 0.40
Total male and female 25 to 34 years C01A Cardiac glycosides 2024* 0.00
Total male and female 25 to 34 years C01C Cardiac stimulants excl. glycosides 2024* 0.34
Total male and female 25 to 34 years C01D Vasodilators used in card. diseases 2024* 0.02
Total male and female 25 to 34 years C01E Other cardiac preparations 2024* 0.03
Total male and female 25 to 34 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.08
Total male and female 25 to 34 years V09G Cardiovascular system 2024* 0.00
Total male and female 35 to 44 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 35 to 44 years C Cardiovascular system 2024* 6.26
Total male and female 35 to 44 years C01 Cardiac therapy 2024* 0.49
Total male and female 35 to 44 years C01A Cardiac glycosides 2024* 0.01
Total male and female 35 to 44 years C01C Cardiac stimulants excl. glycosides 2024* 0.27
Total male and female 35 to 44 years C01D Vasodilators used in card. diseases 2024* 0.13
Total male and female 35 to 44 years C01E Other cardiac preparations 2024* 0.04
Total male and female 35 to 44 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.18
Total male and female 35 to 44 years V09G Cardiovascular system 2024* 0.00
Total male and female 45 to 54 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 45 to 54 years C Cardiovascular system 2024* 16.69
Total male and female 45 to 54 years C01 Cardiac therapy 2024* 1.18
Total male and female 45 to 54 years C01A Cardiac glycosides 2024* 0.05
Total male and female 45 to 54 years C01C Cardiac stimulants excl. glycosides 2024* 0.28
Total male and female 45 to 54 years C01D Vasodilators used in card. diseases 2024* 0.64
Total male and female 45 to 54 years C01E Other cardiac preparations 2024* 0.08
Total male and female 45 to 54 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.47
Total male and female 45 to 54 years V09G Cardiovascular system 2024* 0.00
Total male and female 55 to 64 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 55 to 64 years C Cardiovascular system 2024* 34.40
Total male and female 55 to 64 years C01 Cardiac therapy 2024* 2.78
Total male and female 55 to 64 years C01A Cardiac glycosides 2024* 0.23
Total male and female 55 to 64 years C01C Cardiac stimulants excl. glycosides 2024* 0.31
Total male and female 55 to 64 years C01D Vasodilators used in card. diseases 2024* 1.77
Total male and female 55 to 64 years C01E Other cardiac preparations 2024* 0.12
Total male and female 55 to 64 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.99
Total male and female 55 to 64 years V09G Cardiovascular system 2024* 0.00
Total male and female 65 to 74 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 65 to 74 years C Cardiovascular system 2024* 54.95
Total male and female 65 to 74 years C01 Cardiac therapy 2024* 5.61
Total male and female 65 to 74 years C01A Cardiac glycosides 2024* 0.88
Total male and female 65 to 74 years C01C Cardiac stimulants excl. glycosides 2024* 0.34
Total male and female 65 to 74 years C01D Vasodilators used in card. diseases 2024* 3.44
Total male and female 65 to 74 years C01E Other cardiac preparations 2024* 0.17
Total male and female 65 to 74 years C08D Sel.calcium ch.block.direct cardiac 2024* 1.75
Total male and female 65 to 74 years V09G Cardiovascular system 2024* 0.00
Total male and female 75 years or older A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 75 years or older C Cardiovascular system 2024* 69.93
Total male and female 75 years or older C01 Cardiac therapy 2024* 10.92
Total male and female 75 years or older C01A Cardiac glycosides 2024* 3.09
Total male and female 75 years or older C01C Cardiac stimulants excl. glycosides 2024* 0.24
Total male and female 75 years or older C01D Vasodilators used in card. diseases 2024* 6.52
Total male and female 75 years or older C01E Other cardiac preparations 2024* 0.18
Total male and female 75 years or older C08D Sel.calcium ch.block.direct cardiac 2024* 2.28
Total male and female 75 years or older V09G Cardiovascular system 2024* 0.00
Total male and female 0 to 4 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 0 to 4 years C Cardiovascular system 2024* 0.59
Total male and female 0 to 4 years C01 Cardiac therapy 2024* 0.35
Total male and female 0 to 4 years C01A Cardiac glycosides 2024* 0.00
Total male and female 0 to 4 years C01C Cardiac stimulants excl. glycosides 2024* 0.34
Total male and female 0 to 4 years C01D Vasodilators used in card. diseases 2024* 0.00
Total male and female 0 to 4 years C01E Other cardiac preparations 2024* 0.00
Total male and female 0 to 4 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.00
Total male and female 0 to 4 years V09G Cardiovascular system 2024* 0.00
Total male and female 5 to 9 years A07C Electrolytes with carbohydrates 2024* 0.00
Total male and female 5 to 9 years C Cardiovascular system 2024* 0.75
Total male and female 5 to 9 years C01 Cardiac therapy 2024* 0.57
Total male and female 5 to 9 years C01A Cardiac glycosides 2024* 0.00
Total male and female 5 to 9 years C01C Cardiac stimulants excl. glycosides 2024* 0.56
Total male and female 5 to 9 years C01D Vasodilators used in card. diseases 2024* 0.00
Total male and female 5 to 9 years C01E Other cardiac preparations 2024* 0.00
Total male and female 5 to 9 years C08D Sel.calcium ch.block.direct cardiac 2024* 0.00
Total male and female 5 to 9 years V09G Cardiovascular system 2024* 0.00
Total male and female 10 to 14 years A07C Electrolytes with carbohydrates 2024* 0.00
Source: CBS.
Explanation of symbols

Table explanation


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, age and sex.

Data available from: 2006

Status of the figures:
Figures for 2024 are provisional, figures for previous years are final.

Changes as of December 18, 2025:
- Provisional figures for 2024 have been added, provisional figures of 2023 have been made definite.
- Figures for 2024 do not include DDD's as they are insufficiently reliable.

When will new figures be published?
New figures will be published in the last quarter of 2026.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.